Clinical Trial Update: Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis

View source ↗

Summary

Long-term safety data for CS20AT04 in lupus nephritis were collected from a completed study, with follow-up safety results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• CS20AT04

Snippet

Sponsor: Corestemchemon, Inc. | Conditions: Lupus Nephritis | Status: COMPLETED